Kenneth S. Cohen to Proto-Oncogene Proteins B-raf
This is a "connection" page, showing publications Kenneth S. Cohen has written about Proto-Oncogene Proteins B-raf.
Connection Strength
0.508
-
Efficacy and Safety of Dabrafenib in Pediatric Patients with BRAF V600 Mutation-Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study. Clin Cancer Res. 2019 12 15; 25(24):7303-7311.
Score: 0.160
-
A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory BRAF V600 Mutation-Positive Solid Tumors. Clin Cancer Res. 2019 12 15; 25(24):7294-7302.
Score: 0.157
-
New strategies in pediatric gliomas: molecular advances in pediatric low-grade gliomas as a model. Clin Cancer Res. 2013 Sep 01; 19(17):4553-8.
Score: 0.103
-
BRAF activation induces transformation and then senescence in human neural stem cells: a pilocytic astrocytoma model. Clin Cancer Res. 2011 Jun 01; 17(11):3590-9.
Score: 0.089